Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

  1. Enocsson, H.
  2. Wirestam, L.
  3. Dahle, C.
  4. Padyukov, L.
  5. Jönsen, A.
  6. Urowitz, M.B.
  7. Gladman, D.D.
  8. Romero-Diaz, J.
  9. Bae, S.-C.
  10. Fortin, P.R.
  11. Sanchez-Guerrero, J.
  12. Clarke, A.E.
  13. Bernatsky, S.
  14. Gordon, C.
  15. Hanly, J.G.
  16. Wallace, D.J.
  17. Isenberg, D.A.
  18. Rahman, A.
  19. Merrill, J.T.
  20. Ginzler, E.
  21. Alarcón, G.S.
  22. Chatham, W.W.
  23. Petri, M.
  24. Khamashta, M.
  25. Aranow, C.
  26. Mackay, M.
  27. Dooley, M.A.
  28. Manzi, S.
  29. Ramsey-Goldman, R.
  30. Nived, O.
  31. Steinsson, K.
  32. Zoma, A.A.
  33. Ruiz-Irastorza, G.
  34. Lim, S.S.
  35. Kalunian, K.C.
  36. Inanc, M.
  37. van Vollenhoven, R.F.
  38. Ramos-Casals, M.
  39. Kamen, D.L.
  40. Jacobsen, S.
  41. Peschken, C.A.
  42. Askanase, A.
  43. Stoll, T.
  44. Bruce, I.N.
  45. Wetterö, J.
  46. Sjöwall, C.
  47. Show all authors +
Journal:
Journal of Autoimmunity

ISSN: 1095-9157,  0896-8411

Year of publication: 2020

Volume: 106

Type: Article

DOI: 10.1016/J.JAUT.2019.102340 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus